BehanFM, IorioF, PiccoG, et al.Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature, 2019; 568:511–516. DOI: 10.1038/s41586-019-1103-9.
2.
TsherniakA, VazquezF, MontgomeryPG, et al.Defining a cancer dependency map. Cell, 2017; 170:564–576.e16. DOI: 10.1016/j.cell.2017.06.010.
3.
LiW, XuH, XiaoT, et al.MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol, 2014; 15:554. DOI: 10.1186/s13059-014-0554-4.
4.
XiaoT, LiW, WangX, XuH, et al.Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proc Natl Acad Sci U S A, 2018; 115:7869–7878. DOI: 10.1073/pnas.1722617115.
5.
MainardiS, Mulero-SánchezA, PrahalladA, et al.SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo. Nat Med, 2018; 24:961–967. DOI: 10.1038/s41591-018-0023-9.
